Skip to content
Lower risk Drug recall · FDA · Published May 13, 2022

GlaxoSmithKline Tivicay Tablets: Incorrect Expiration Date on Labels

GlaxoSmithKline recalls Tivicay 50mg tablets with incorrect expiration date labels (Jan 2027 instead of Sep 2026). This affects prescription bottles sold in the US. Check your label for lot number 2A9E.

🇺🇸 FDA recall #D-0896-2022DrugGlaxoSmithKline ›
Take action

Contact the company

Recalling firmGlaxoSmithKline LLC1011 N Arendell Ave · Zebulon, NC 27597-2309
✎ GovInfoNow plain-language explainer

GlaxoSmithKline is recalling Tivicay (dolutegravir) 50mg tablets due to incorrect expiration dates on labels. This could lead to medication safety issues if patients use expired products. The recall affects prescription bottles with specific lot numbers. Read more at govinfonow.com/recall/34714-glaxosmithkline-tivicay-tablets-incorrect-expiration-date-on-labels.

Source Summary by GovInfoNow · govinfonow.com/recall/34714-glaxosmithkline-tivicay-tablets-incorrect-expiration-date-on-labels · Updated August 18, 2026 · FDA enforcement record: FDA #D-0896-2022

Cite this page

“GlaxoSmithKline Tivicay Tablets: Incorrect Expiration Date on Labels.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34714-glaxosmithkline-tivicay-tablets-incorrect-expiration-date-on-labels. Based on FDA recall #D-0896-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0896-2022%22&limit=1).

The Food and Drug Administration announced on May 13, 2022, that GlaxoSmithKline LLC voluntarily recalled Tivicay (dolutegravir) Tablets 50 mg due to labeling errors. The hazard involves incorrect or missing lot and expiration dates on the product packaging. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: GlaxoSmithKline
  • Product: Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle
  • NDC: 49702-228-13
  • Lot: 2A9E
  • Expiration Date on Label: 1/2027
  • Quantity: 328 bottles
  • Distribution: Nationwide in the U.S.

The hazard

The recall addresses labeling issues where incorrect or missing lot and/or expiration dates were printed on the product. Specifically, an incorrect expiration date of January 2027 was printed, whereas the correct expiration date is September 2026.

Context

GovInfoNow's records show GlaxoSmithKline LLC has 11 other recalls on record since October 8, 2012. Other recent recalls of similar products include Tivicay PD Recall: Incorrect Expiration Date on Carton (May 17, 2024) and GlaxoSmithKline ANORO ELLIPTA inhaler recall (December 12, 2023). Premier Dental Products issued a recall for incorrect expiration date on Ferric Subsulfate Solution on April 14, 2026, while OurPharma recalled Fentanyl Injection due to IV bag expiry discrepancy on September 3, 2026.

How to tell if you have this one

Check your Tivicay 50mg tablets for a label with lot number 2A9E and an expiration date of January 2027. The product was manufactured for ViiV Healthcare in RTP, NC.

  • Brand
    GlaxoSmithKline
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Label

    Look for the lot number 2A9E and expiration date of January 2027 on the product label.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: May 13, 202212. FDA classified it Class III: May 25, 202223. Published in FDA’s Enforcement Report: Jun 1, 202234. FDA terminated the recall: Aug 17, 2023420222023
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0896-2022 (May 13, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0896-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA